Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
OVID
Stock Latest News
Weekend Updates
CWAN, HTBK, OVID, MCFT, WHWK Trending With Analysts
1M ago
CWAN
HTBK
Premium
The Fly
Ovid Therapeutics initiated with an Outperform at LifeSci Capital
1M ago
OVID
Premium
Ratings
Ovid Therapeutics: Positive KCC2 Platform Progress and Underappreciated Pipeline Optionality Support Reiterated Buy Rating
1M ago
OVID
Premium
Ratings
Ovid Therapeutics: De-Risked KCC2 Platform and OV329 as Key Drivers of Long-Term Growth Support Buy Rating
1M ago
OVID
Premium
Ratings
Ovid Therapeutics: Early KCC2 Proof-of-Mechanism and High-Potency OV4071 Pipeline Support Buy Rating and Attractive Long-Term Risk‑Reward
1M ago
OVID
Premium
Company Announcements
Ovid Therapeutics Advances Oral KCC2 Activators After OV350 Data
1M ago
8K
OVID
Premium
The Fly
Ovid Therapeutics reports Phase 1 results for KCC2, OV350 IV
1M ago
OVID
Premium
The Fly
Ovid Therapeutics files to sell 125.06M shares of common stock for holders
2M ago
OVID
Premium
Company Announcements
Ovid Therapeutics Stockholders Approve Key Proposals
2M ago
8K
OVID
Premium
The Fly
Ovid Therapeutics initiated with a Buy at Roth Capital
2M ago
OVID
Premium
The Fly
Ovid Therapeutics appoints Kaufmann as Chief Medical Officer
2M ago
OVID
Premium
The Fly
Ovid Therapeutics price target raised to $2 from $1.50 at H.C. Wainwright
2M ago
OVID
Premium
The Fly
Leerink bullish on Ovid Therapeutics, initiates with an Outperform
2M ago
OVID
Premium
The Fly
Ovid Therapeutics initiated with an Outperform at Leerink
2M ago
OVID
Premium
Ratings
Ovid Therapeutics: Promising Pipeline and Strong Financials Justify Buy Rating
3M ago
OVID
Premium
Company Announcements
Ovid Therapeutics Reports Q3 2025 Financial Results
3M ago
OVID
Premium
The Fly
Ovid Therapeutics reports Q3 EPS (17c), consensus (15c)
3M ago
OVID
Premium
The Fly
Ovid Therapeutics appoints Alexander as CEO, Levin as Executive Chairman
3M ago
OVID
Premium
Pre-Earnings
Ovid Therapeutics (OVID) Q3 Earnings Cheat Sheet
3M ago
OVID
Premium
The Fly
Ovid Therapeutics price target raised to $5 from $3 at B. Riley
4M ago
OVID
Premium
The Fly
Ovid Therapeutics initiated with an Outperform at Oppenheimer
4M ago
OVID
Premium
Company Announcements
Ovid Therapeutics Secures $175.1M in Private Placement
4M ago
8K
OVID
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
